Adam O’Dell’s “X.AI” presentation has been getting a lot of attention in financial circles.
Adam pitches the idea that AI could become one of the most significant developments in the world. He even claims that investors who get in now can stake their claim in AI’s $80 Trillion Windfall over the next 10 years.
In this piece, I walk you through the presentation to give you a sense of what Adam O’Dell is talking about.
Before I start…
If you’re tired of scams and want a real solution for making money online, check out my no.1 recommendation.
This is the best business to start in 2023 and made me over 27k last month alone:
Go here to see my no.1 recommendation for making money online
RECOMMENDED: Go here to see my no.1 recommendation for making money online
What is Adam O’Dell xAI?
Adam O’Dell’s “X.AI” presentation focuses on Artificial Intelligence.
Adam starts the presentation waxing lyrical about Artificial Intelligence (AI) claiming that it could have a big impact on our lives and make the people who invest wisely in related companies very rich.
He says that big tech companies and multiple government agencies are working on AI-based solutions for their clients and the country.
He even reveals a bill by the Senate that has to do with AI that was passed with a bipartisan vote.
Amid these developments, Adam is focused on one tiny company that is heavily involved in an industry called “x.AI.”
He says that investing in this company now will earn you big returns in the months and years to come.
After sitting through the presentation, it becomes obvious that what he is referring to as “x.AI” is the biotech industry.
So, Adam is talking about investing in a company that is using AI and the biotech industry.
We’ve seen other investment analysts talk about biotech companies using AI to develop drugs and it looks like Adam is hopping on the bandwagon.
The drug development process takes an enormous amount of time and a lot of money has to be invested. By some estimates, it costs $2.6 billion and takes ten years to bring a drug to market.
AI can help with all the stages of drug discovery. Many biotech startups have raised money because they use AI to streamline the process.
How is AI used in developing new drugs?
First, AI helps analyze existing literature to determine how potential drugs will interact with targets.
In preclinical development, potential drug targets are tested on animal models. With AI, you can run trials more smoothly and researchers have an easier time predicting how a drug will interact with the animal model.
When a manufacturer gets FDA approval in preclinical development, the next phase is the clinical trials. It is a four-stage process that is considered the most expensive and time-consuming stage of drug development.
AI can play the role of monitoring clinical trials to generate a more extensive set of data faster. It can also personalize the trial experience.
AI can identify many compounds in a relatively short period and at a quarter of the cost of traditional methods.
Going back to Adam O’Dell’s presentation, he reveals that the company he is teasing is working on AI-related therapies for Cancer.
It specializes in developing solutions that have a high success rate in cancer diagnosis. It has come up with a way to predict more stable and effective outcomes for cancer patients by using data generated by an AI-based system.
All the details about this company are in a special report that Adam wrote called NGS Fortunes: The #1 x.AI Company Working to Eradicate Cancer.
To read this report, you have to subscribe to Adam’s newsletter, Green Zone Fortunes.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Who is Adam O’Dell?
Adam O’Dell is an investment analyst who holds the Chartered Market’s Technician (CMT) qualification and MBA.
He is a former hedge fund manager who began publishing his trade recommendations online in 2012. Since he started writing about his investments, he’s beaten the returns of some seasoned investors and beaten the S&P 500 by more than five times.
Adam’s investment approach is designed to find profits in any asset class — stocks, bonds, gold. His goal is to find moneymaking opportunities in the markets at any given time.
Besides this presentation, he has been behind others like Imperium Stock and Wednesday Windfalls.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Green Zone Fortunes Review
Adam O’Dell’s Green Zone Fortunes is published by a firm called Money and Markets.
It is a multifaceted investment research service that focuses on the latest big investment opportunity and a weekly email that has the Green Zone Ratings.
The ratings highlight the top 10 best-performing stocks and the top 10 worst-performing stocks, to help you successfully invest with confidence.
When you sign up for Green Zone Fortunes, you get:
A 1-Year Membership to Green Zone Fortunes
Adam O’Dell reveals the company he regards as the No. 1 stock in the markets. He sends that to your email in his newsletter, including detailed research and analysis.
You also get 24/7 access to the members-only website where you’ll find his live model portfolio and past research reports.
Access to the Green Zone Fortunes “Weekly Hotlist”
Each week, Adam analyzes up to 8,000 U.S. stocks through his Green Zone Rating system. He then sends the top 10-rated stocks to you every Wednesday.
Special Reports
If you sign up, you will receive the following reports:
- NGS Fortunes: The #1 x.AI Company Working to Eradicate Cancer
- Precision Profits: The Tiny Company Creating the Blueprint for Personalized Drug Discovery
- Tomorrow’s Edge: The x.AI Company Treating HIV and Infectious Disease
These reports are all about companies using AI to enhance healthcare research.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Green Zone Fortunes Pricing
The first year of your subscription costs $47.
After that, the subscription will auto-renew for $79 and that will be the annual rate every year after that.
You can always cancel your subscription.
The Green Zone Fortunes Refund Policy
The subscription has a 365-day, 100% money-back guarantee.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Is Adam O’Dell x.AI Legit?
Adam O’Dell’s “x.AI” presentation is legit.
Artificial intelligence is expected to take a bigger role in drug discovery. Its significance in the market is expected to grow in the next few years due to an increase in the number of cross-industry collaborations.
The number of venture capital investments is on the rise and there has also been an increase in R&D activities for the use of AI technology. All these factors contribute to a rise in the importance of AI in the drug discovery process.
There is a growing awareness of the importance of artificial intelligence in the healthcare industry.
That being said, Adam’s recommendations may fail to do as well as he is telling us. You should always be open to that possibility.
Closing Remarks on Adam O’Dell xAI
Adam O’Dell’s “xAI” is his latest pitch that focuses on the healthcare industry. This time, he is talking about investing in companies that use AI in drug discovery.
Other investment analysts have been talking about such companies and it looks like Adam is joining the frenzy. These people have been telling us that investing in a company that is using AI to streamline the drug discovery process is likely to earn you good returns.
If you intend to invest in such a company, you should do more research before you pull the trigger.
Before you leave
If you’re tired of scams and want a real solution for making money online, check out my no.1 recommendation.
This is the best business to start in 2023 and made me over 27k last month alone:
Go here to see my no.1 recommendation for making money online
David Fortune has been the editor NoBSIMReviews.com since 2019. He is an expert at writing content on stock advisory services, side hustles, reviewing online business opportunities and many more topics. You can learn more about David on our about us page.